Evidence map›Paper›PMID 30905010›Full record

ArticleInternational journal of computer assisted radiology and surgery2019

Deep neural maps for unsupervised visualization of high-grade cancer in prostate biopsies.

Alireza Sedghi, Mehran Pesteie, Golara Javadi, Shekoofeh Azizi, Pingkun Yan, Jin Tae Kwak, Sheng Xu, Baris Turkbey, Peter Choyke, Peter Pinto and 4 more

Abstract read
In one paragraph

Article in International journal of computer assisted radiology and surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Coarse label refinement for improving prostate cancer detection in ultrasound imaging.International journal of computer assisted radiology and surgery · 2022
    Article
  7. Article
  8. Article
  9. Improving detection of prostate cancer foci via information fusion of MRI and temporal enhanced ultrasound.International journal of computer assisted radiology and surgery · 2020
    Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alireza SedghiQueen's University, Kingston, ON, Canada. Sedghi@cs.queensu.ca.ORCID http://orcid.org/0000-0002-6341-2577
Mehran PesteieThe University of British Columbia, Vancouver, BC, Canada.
Golara JavadiThe University of British Columbia, Vancouver, BC, Canada.
Shekoofeh AziziThe University of British Columbia, Vancouver, BC, Canada.
Pingkun YanRensselaer Polytechnic Institute, Troy, NY, USA.
Jin Tae KwakSejong University, Seoul, South Korea.
Sheng XuThe National Institutes of Health Research Center, Baltimore, MD, USA.
Baris TurkbeyThe National Institutes of Health Research Center, Baltimore, MD, USA.
Peter ChoykeThe National Institutes of Health Research Center, Baltimore, MD, USA.
Peter PintoThe National Institutes of Health Research Center, Baltimore, MD, USA.
Bradford WoodThe National Institutes of Health Research Center, Baltimore, MD, USA.
Robert RohlingThe University of British Columbia, Vancouver, BC, Canada.
Purang AbolmaesumiThe University of British Columbia, Vancouver, BC, Canada.
Parvin MousaviQueen's University, Kingston, ON, Canada.

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
Prostate SectionZIABC011081 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PINTO, PETER · 2009 to 2025
$15.2M
Prostate Cancer ImagingZ01BC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2005 to 2008
$2.1M
Intramural NIH HHS Z01 BC010655Intramural NIH HHS ZIA BC011081
6 · The paper itself

Abstract

Prostate cancer (PCa) is the most frequent noncutaneous cancer in men. Early detection of PCa is essential for clinical decision making, and reducing metastasis and mortality rates. The current approach for PCa diagnosis is histopathologic analysis of core biopsies taken under transrectal ultrasound guidance (TRUS-guided). Both TRUS-guided systematic biopsy and MR-TRUS-guided fusion biopsy have limitations in accurately identifying PCa, intraoperatively. There is a need to augment this process by visualizing highly probable areas of PCa. Temporal enhanced ultrasound (TeUS) has emerged as a promising modality for PCa detection. Prior work focused on supervised classification of PCa verified by gold standard pathology. Pathology labels are noisy, and data from an entire core have a single label even when significantly heterogeneous. Additionally, supervised methods are limited by data from cores with known pathology, and a significant portion of prostate data is discarded without being used. We provide an end-to-end unsupervised solution to map PCa distribution from TeUS data using an innovative representation learning method, deep neural maps. TeUS data are transformed to a topologically arranged hyper-lattice, where similar samples are closer together in the lattice. Therefore, similar regions of malignant and benign tissue in the prostate are clustered together. Our proposed method increases the number of training samples by several orders of magnitude. Data from biopsy cores with known labels are used to associate the clusters with PCa. Cancer probability maps generated using the unsupervised clustering of TeUS data help intuitively visualize the distribution of abnormal tissue for augmenting TRUS-guided biopsies.

Indexed as

Biopsy, Large-Core NeedleEarly Detection of CancerHumansImage-Guided BiopsyMagnetic Resonance ImagingMaleNeoplasm GradingProstateProstatic NeoplasmsUltrasonographyCancer diagnosisDeep learningDeep neural mapsProstate cancerSelf-organizing mapsTemporal enhanced ultrasound

Identifiers

PMID30905010
PMCPMC8258684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.